No significant differences were detected between patients with and without pneumonitis regarding menopausal status, history of thoracic radiotherapy, chemotherapy status before CDK4/6i therapy, the line of CDK4/6i therapy, or lung metastases (p > 0.05). Here, CDK4 is linked to pneumonitis.